HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Necrobiotic xanthogranuloma in a human T-lymphotropic virus type 1 carrier.

Abstract
A 67-year-old man who had necrobiotic xanthogranuloma associated with paraproteinemia is described. He was a human T-lymphotropic virus type 1 (HTLV-1) carrier who had a high titer of circulating anti-HTLV-1 antibodies and neurologic abnormalities that suggested HTLV-1-associated myelopathy. The patient's necrobiotic xanthogranuloma and neurologic symptoms improved after he received four 5-day courses of melphalan, 2 mg/day, and prednisolone, 20 mg/day, at 4-week intervals.
AuthorsM Nishimura, Y Takano-Nishimura, I Yano, N Hayashi, S Toshitani
JournalJournal of the American Academy of Dermatology (J Am Acad Dermatol) Vol. 27 Issue 5 Pt 2 Pg. 886-9 (Nov 1992) ISSN: 0190-9622 [Print] United States
PMID1469152 (Publication Type: Case Reports, Journal Article)
Chemical References
  • HTLV-I Antibodies
Topics
  • Aged
  • Granuloma (immunology, pathology)
  • HTLV-I Antibodies (analysis)
  • HTLV-I Infections (immunology, pathology)
  • Humans
  • Male
  • Necrobiotic Disorders (immunology, pathology)
  • Paraproteinemias
  • Xanthomatosis (immunology, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: